UBS Group’s Alpha Cognition ACOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5K Buy
1,456
+1,018
+232% +$6.37K ﹤0.01% 8547
2026
Q1
$2.4K Sell
438
-489
-53% -$2.78K ﹤0.01% 9283
2025
Q4
$6.03K Buy
927
+786
+557% +$4.96K ﹤0.01% 8594
2025
Q3
$918 Sell
141
-31,758
-100% -$289K ﹤0.01% 9495
2025
Q2
$298K Buy
+31,899
New +$234K ﹤0.01% 6447
2025
Q1
Sell
-8,654
Closed -$51K 10912
2024
Q4
$51K Buy
+8,654
New +$48.6K ﹤0.01% 7280

Other funds holding ACOG

UBS Group's ACOG Position: Q2 2026 in Review

UBS Group increased its Alpha Cognition (ACOG) stake by 232% in Q2 2026, buying an estimated $6.37K and bringing the position to 1,456 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #8547.

UBS Group first reported a position in ACOG in Q4 2024 and has held it in 6 quarters since. The position peaked at $298K in Q2 2025. 26 funds tracked by Wall St. Rank hold ACOG as of Q2 2026.

  • UBS Group held 1,456 shares of Alpha Cognition worth $10.5K as of Q2 2026.
  • UBS Group bought 1,018 Alpha Cognition shares in Q2 2026, an estimated $6.37K.
  • Alpha Cognition made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8547 holding.
  • UBS Group first reported a position in Alpha Cognition in Q4 2024 and has held it in 6 quarters since.
  • UBS Group's Alpha Cognition position peaked at $298K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Alpha Cognition as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.